Medical Research Finder

Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

© 2026 meRfi®

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

AuthorsReferences (Sources)

meRfi® AI Chat

XXX - Alfa-linolenic acid (ALA) + Fructooligosaccharides (FOS) + Inulin-type fructans (ITF) / Inulin & Adiposity / Obesity

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Register for a free trial

Navigation

Contents

Background:

Our study aimed to assess how the cardiovascular risk profile in obese patients responded after incorporating a cookie enriched with ALA, FOS, and inulin into their diet (1).

Study overview:

XXX - Alfa-linolenic acid (ALA) + Fructooligosaccharides (FOS) + Inulin-type fructans (ITF) / Inulin & Adiposity / Obesity is a double blind randomized clinical trial evaluating Alfa-linolenic acid (ALA) + Fructooligosaccharides (FOS) + Inulin-type fructans (ITF) / Inulin vs placebo in 30 eligible patients with adiposity / obesity.

Outcome measures:

Dietary intake, weight, fat mass, [blood pressure](brain://PnVB…

References (Sources)

Double blind randomized clinical trial controlled by placebo with an alpha linoleic acid and prebiotic enriched cookie on risk cardiovascular factor in obese patients
de Luis et al. 2011 Nutr Hosp 26: 827–33

AI Chat

7/1/2026

Chat with our artificial intelligence: